9999999997-15-000806.txt : 20150206 9999999997-15-000806.hdr.sgml : 20150206 20150206113600 ACCESSION NUMBER: 9999999997-15-000806 CONFORMED SUBMISSION TYPE: CT ORDER PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20150206 DATE AS OF CHANGE: 20150206 20150206 20150206 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SPECTRUM PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000831547 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930979187 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CT ORDER SEC ACT: 1934 Act SEC FILE NUMBER: 001-35006 FILM NUMBER: 15583017 BUSINESS ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 BUSINESS PHONE: 702-835-6300 MAIL ADDRESS: STREET 1: 11500 S. EASTERN AVE., SUITE 240 CITY: HENDERSON STATE: NV ZIP: 89052 FORMER COMPANY: FORMER CONFORMED NAME: NEOTHERAPEUTICS INC DATE OF NAME CHANGE: 19960819 FORMER COMPANY: FORMER CONFORMED NAME: AMERICUS FUNDING CORP DATE OF NAME CHANGE: 19920703 CT ORDER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-"B6UM;6U#0HQ(#`@;V)J#0H\/"]4>7!E+T-A=&%L;V7!E+U!A9V5S+T-O=6YT(#$O2VED'0O26UA9V5"+TEM86=E0R]);6%G94E=(#X^+TUE9&EA0F]X6R`P(#`@-C$R M(#2]#4R]$979I8V521T(^/B]486)S+U,O4W1R=6-T4&%R96YT M)R-66MOV\82_6[`_V&!?B$!>\-] M\7%1%'!D)U7OM1TX"E"@N0AD2XH(2*(K4FWS[SLS2TI:B4MO@BAZG)V9G<>9 MV25[]XG]_/.[^]'XEB6__,+>WX[8^\GEQ;L/@@G))HO+"\$2^"M8D?!$:I8E M.2\TFZPO+Q+V'5\^7E[\$;'X_VSRV^7%'2QF=_NP16 MQI,Q?J!OZ#=V@Q;?LKO?8R&BT:_T\6.<6P@;/=['UR:ZQUU]QHW0HO'C@VFDDOPADP/>?(!S9N#&<]HP!;>[/#-=(OF_6#I%9.),#[W MZH+GF2N0>4,A>5'XL6<[R`;R2\C`),W[XID*KB4S17Y(TL>GV[LG]C$NHJ<; MW/G#9/R`T6+Q=1&-'A_`31">V[N'"89O?/,_1NGW!-$4"63A?=RF`P`\$30) M-[FK==#THL]T*(V"F5R?5`8:/_EUGY/L[?2DM[^/X$=(S8\Q;,*NO,&O:)/L M\0.X@XE":>^6%!>N-5"DR6!F2WZ*%!**/2,&9,=LHLV^HHOF-\O M\*_9QAGF-\1RC0&EZ'[""E@>DIY^F;[@VWE7#DT97^ISJ4@1Z."][A?%&=9GAX)>A[^V]D#D)2!&&9YV4;]^^ M^2("3-J#/OGC,S@M*%>/%P\;;)RI2GJF*I-(+DR0P+XFV4K1><62R!2_0VX!=H(&$TL@F$%RD7G" M<^/JKG?/:Z3NLB'2FL_8-$ZC#=$[8^95I)'#\< M94\^K$ZX3%WL;C6'U'KVK<@,=#5G@:_V=`83QXEPZ;.Z"V6FL3(L>#N'%O#G M#G=;X_8U\G@1?<<.Z`VSEMB;'#GHO@U#,?_@^F:^J4MP9+4@E[-7TO-76>UJ MZJ5['=!B4KNX0;"7CB2J%R[VOSXL-&MS(M=K M+S3K4^RB7(%;8BPG7U"50&H.TJ"4YNF)!O0C3>KHRUU7TY!0(HU^Q!+R5^&T MGOBF=0W],#^1R;W8`@].7EO/N;1O7.]R2:28&II)?7^QCY&/L> M*A$]57O+6R']'"]!-\]899F32OF5"I=H8P[NWS142S6Q-7M&F`V!MU,JRMIC M)2>=`D2)J&T7LK]=$-,X#'[2,;H:]78-+7(\A3EV-,MI`W5,;(GXC]W9!()6I3(2C6;UNP%ZW^S*&=(1):="$)@]E*MU_,M;5-'R&=$ M%>3X1;G!_6^Z7TIR$1":%J/3<#IO*S;;>7Q!S8=HRG M`,NVH&OOC1L*U14S[`NG^/$1N9_#Y"Z_1F#4\]<87K]&&OY/HZN]4;?E7R7U M@K9-C*KM*U&TTXC1=-CU!E>@*IJUEUVMUVPV;]"OVW6YP32Y9Q5K[OGP]"PH@C\B!5D^JRL7U953=^0F7;JX`R=E-IVA5&: ME1O"4/L#`5+84KEB/6T%]VTS4':TWB8)OEMMI]I[L@:CZ!TY9,?(D@<^+2$'LP M:40@-$]#H5W\@3U,:/R#L&W\@[!M_'W8\TSNN]WK=B(ES\*D]%V.=5*2/(!' M6W\<8_?G&.+!445'[;4=F^JV@?N24VJ>%*ZXJ^.QT4Y_EGU#)@7O)9"DQ#[6 MT>7`6S-!ZS6)#Y%JXV.'X]UUK=CO!)UQA4OINR#HI^(@K3$K?,Z5. M"CZ8"LS%,*RMS3"LKC,( MVWHS!-MY,PC;>C,$VWGS&(NG7SK!0J7_UIY5B!#FJYEWNLH,SPJ_SO.H#)S^ M)3[Q"XU*$+:-2A"VC4H(MHM*$+:-2@BVB\HQ]O/Q8RD*3S-%]NSF"]\S5('/ M!;Q:S^,R<)\B\2%JD)"!$17]&W2SHP8F5(%/$,,2)`AJ\R,(:M,C!-IF1Q#4 M)D<(M,T-'_37!E+T9O;G0O4W5B='EP92]47!E+T9O;G1$97-C/K2I4G=O[Y/+;_UG6>++F*@B-7D[-,KB$7A-CB MXXD=<0C$3&(CL9"$BMB3MS5>D`\-<40VU(!$)JXI.N0U%&-$$E7@BJ.JLB1, M=28)U94G\=0@5P(U%201LT,N%6(-$:IQD`C*<77$A.08@QZ%G/?0!<0&.O!"@`Z\B&5Y\&*`"/K*YLFPTAH-%FBK#,7J+,18K*".DQ-S MD\66;LW"W)B[C]=D%N.P6X[GF[0UE_=D'\C'_U#BIN?PO-39'Z* MGY\2YJ?$^2G5_)1Z?DI3<)0EQU]P_J[``*[``:[``J[``Z[`!*[`!:[`!J[` M!US@`R[Y'2CP`1?X@`M\P`4^X`(?<($/N,`'7.`#*?"!%/A`_NX#^YG3#N/? MO]Y9D*_Z*=0:FBFPU>`TL`;1H'FXZZ<0-2B%E<)*$:6(4D0IHA11BBA%E")* M$:6(4KQ2O%*\4KQ2O%*\4KQ2O%+\1'F@_8X<[,#=D-)MWX_FMM^DJ_8U7_EY MK[!3J9O>YLL_CTR_G(HY>'N=WL?+]$%NC[X`J^O'9*YS<]X]?77N('WLW\TB M+4?S([5/:=#GG//Y_+/;K+NT>&YSA7G@6P=".Z[[;M\?QO7O%@]3[U<_O#SV M_8LYZY>[+6J:1MZ>4QKUL*_:Y=`?]+\_HSWHGZW;3;\Z&%ALUD_I0*OS0+8: MVJVY6*]V0]JO]7JW?;O/_Q##U^[^/UXZ/OH#O#K-\PT*96YD@M)!&MMG7:O')E9@T*-3,Q,PT*)25%3T8-"GAR968-"C`@,`T*=')A:6QE M<@T*/#PO4VEZ92`U,B]2;V]T(#$@,"!2+TEN9F\@.2`P(%(O241;/#4T,D8Y M.#')E9@T*-C4P.`T*)25%3T8_ ` end